These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

958 related items for PubMed ID: 19111771

  • 1. Atrial fibrillation in patients with implantable defibrillators.
    Sakhuja R, Shah AJ, Keebler M, Thakur RK.
    Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771
    [Abstract] [Full Text] [Related]

  • 2. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH.
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T, Hochadel M, Strauss M, Skarlos A, Seidl K, Zahn R.
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA.
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.
    Borleffs CJ, van Rees JB, van Welsenes GH, van der Velde ET, van Erven L, Bax JJ, Schalij MJ.
    J Am Coll Cardiol; 2010 Mar 02; 55(9):879-85. PubMed ID: 20185038
    [Abstract] [Full Text] [Related]

  • 10. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S, Murawski MM.
    J Cardiovasc Pharmacol Ther; 2007 Sep 02; 12(3):175-80. PubMed ID: 17875944
    [Abstract] [Full Text] [Related]

  • 11. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM, Sharma S, Dougherty AH, Kantharia BK.
    Cardiol J; 2009 Sep 02; 16(5):473-6. PubMed ID: 19753529
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, Kavesh NG, Wood M, Daoud E, Massumi A, Schuger C, Shorofsky S, Wilkoff B, Glikson M.
    Circulation; 2006 Jun 27; 113(25):2871-9. PubMed ID: 16769912
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P, Trappe HJ, Meissner A.
    Europace; 2007 Dec 27; 9(12):1161-2. PubMed ID: 17913694
    [Abstract] [Full Text] [Related]

  • 16. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, PREPARE Study Investigators.
    J Am Coll Cardiol; 2008 Aug 12; 52(7):541-50. PubMed ID: 18687248
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. How to avoid inappropriate therapy.
    Israel CW.
    Curr Opin Cardiol; 2008 Jan 12; 23(1):65-71. PubMed ID: 18281830
    [Abstract] [Full Text] [Related]

  • 20. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ, MADIT II Investigators.
    J Am Coll Cardiol; 2008 Apr 08; 51(14):1357-65. PubMed ID: 18387436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.